Methamphetamine dependence
Conditions
Interventions
Experimental Group:Subjects will receive MRCC treatment six times in addition to routine therapy, with each session lasting 25 minutes in a virtual reality environment. Each session includes 10 minute
Control Group:The subjects receive sham-MRCC treatment 6 times, each lasting 25 minutes, with neutral videos in a virtual reality setting, in addition to their routine treatment.
Sponsors
Peking University Sixth Hospital
Eligibility
Sex/Gender
All
Age
18 Years to 65 Years
Inclusion criteria
Inclusion criteria: Meeting the DSM-5 diagnostic criteria for methamphetamine use disorder; abstinence period of over two weeks; aged 18-65 years; right-handed; normal vision and hearing.
Exclusion criteria
Exclusion criteria: a. A history of or currently present neurological disorders; b. A history of or currently present severe cardiovascular, cerebrovascular, hepatic, renal, or other major diseases; c. A history of or currently present other psychiatric disorders, such as bipolar disorder or schizophrenia.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The score on the Visual Analog Scale (VAS); | — |
Secondary
| Measure | Time frame |
|---|---|
| The reduction rate of each score before and after the intervention of amphetamine questionnaire (DSQ);The score on the Beck Depression Inventory (BDI);Beck Anxiety Inventory (BAI) score;The score on the Barratt Impulsiveness Scale (BIS-11);Heart Rate Variability (HRV);Blood pressure change;Skin Conductance Response;Electroencephalography (EEG);Biological index;Other scale indicators;functional magnetic resonance imaging; | — |
Countries
China
Contacts
Public ContactHongqiang Sun
Peking University Sixth Hospital
Outcome results
None listed